1
RESPIRATORY
RESPIRATORY PRACTICE EXAM QUESTIONS
WITH CORRECT VERIFIED SOLUTIONS 100%
GUARANTEED PASS (LATEST UPDATE)
Sharon is a 29-year-old woman with moderate persistent asthma. She is not
using prescribed inhaled corticosteroids, but is using albuterol PRN to
relieve her cough and wheeze with reported satisfactory clinical effect.
Currently she uses about two albuterol metered-dose inhalers per month
and is requesting a prescription refill. You consider that:
A. her asthma is well controlled and albuterol use can continue.
B. excessive albuterol use is a risk factor for asthma death.
C. her asthma is not well controlled and salmeterol (Serevent) should be
added to relieve bronchospasm and reduce her albuterol use.
D. her asthma has better control with albuterol than inhaled
corticosteroids. - ANS ✓B
In the treatment of asthma, leukotriene receptor antagonists should be
used as:
A. controllers to prevent bronchospasm.
B. controllers to inhibit inflammatory responses.
C. relievers to treat acute bronchospasm.
D. relievers to treat bronchospasm and inflammation. - ANS ✓B
According to the National Asthma Education and Prevention Program
Expert Panel Report-3 (NAEPP EPR-3) guidelines, which of the following is
not a risk for asthma death?
Page 1 of 28
, 2
RESPIRATORY
A. hospitalization or an emergency department visit for asthma in the past
month
B. current use of systemic corticosteroids or recent withdrawal from
systemic corticosteroids
C. difficulty perceiving airflow obstruction or its severity
D. rural residence - ANS ✓D
An 18-year-old high school senior presents, asking for a letter stating that
he should not participate in gym class because he has asthma. The most
appropriate action is to:
A. write the note because gym class participation could trigger asthma
symptoms.
B. excuse him from outdoor activities only to avoid pollen exposure.
C. assess his level of asthma control and make changes in his treatment
plan if needed so he can participate.
D. write a note excusing him from gym until his follow-up exam in 2
months. - ANS ✓C
You see a 34-year-old man with moderate persistent asthma who has a
severe asthma flare and a regimen of oral prednisone is being considered.
Which of the following is true?
A. A taper is needed for prednisone therapy lasting longer than 4 days.
B. A taper is not needed if the prednisone regimen is for 7 days or less.
C. A taper is not needed regardless of duration of prednisone therapy.
D. A taper is needed if the patient is taking concomitant inhaled
corticosteroids. - ANS ✓B
After inhaled corticosteroid is initiated, improvement in control is usually
seen:
Page 2 of 28
, 3
RESPIRATORY
A. on the first day of use.
B. within 2 to 8 days.
C. in about 3 to 4 weeks.
D. in about 1 to 2 months. - ANS ✓B
Compared with albuterol, levalbuterol (Xopenex) has:
A. a different mechanism of action.
B. the ability potentially to provide greater bronchodilation with a lower
dose.
C. an anti-inflammatory effect similar to that of an inhaled corticosteroid.
D. a contraindication to use in elderly patients. - ANS ✓B
Which of the following is consistent with the NAEPP comment on the use of
inhaled corticosteroids (ICS) for a child with asthma?
A. The potential but small risk of delayed growth with ICS is well balanced
by their effectiveness.
B. ICS should be used only if leukotriene modifiers fail to control asthma.
C. Permanent growth stunting is consistently noted in children using ICS.
D. Leukotriene modifiers are equal in therapeutic effect to the use of a long-
acting beta2-agonist. - ANS ✓A
A potential adverse effect from ICS use is:
A. oral candidiasis.
B. tachycardia.
C. gastrointestinal upset.
D. insomnia. - ANS ✓A
Page 3 of 28
RESPIRATORY
RESPIRATORY PRACTICE EXAM QUESTIONS
WITH CORRECT VERIFIED SOLUTIONS 100%
GUARANTEED PASS (LATEST UPDATE)
Sharon is a 29-year-old woman with moderate persistent asthma. She is not
using prescribed inhaled corticosteroids, but is using albuterol PRN to
relieve her cough and wheeze with reported satisfactory clinical effect.
Currently she uses about two albuterol metered-dose inhalers per month
and is requesting a prescription refill. You consider that:
A. her asthma is well controlled and albuterol use can continue.
B. excessive albuterol use is a risk factor for asthma death.
C. her asthma is not well controlled and salmeterol (Serevent) should be
added to relieve bronchospasm and reduce her albuterol use.
D. her asthma has better control with albuterol than inhaled
corticosteroids. - ANS ✓B
In the treatment of asthma, leukotriene receptor antagonists should be
used as:
A. controllers to prevent bronchospasm.
B. controllers to inhibit inflammatory responses.
C. relievers to treat acute bronchospasm.
D. relievers to treat bronchospasm and inflammation. - ANS ✓B
According to the National Asthma Education and Prevention Program
Expert Panel Report-3 (NAEPP EPR-3) guidelines, which of the following is
not a risk for asthma death?
Page 1 of 28
, 2
RESPIRATORY
A. hospitalization or an emergency department visit for asthma in the past
month
B. current use of systemic corticosteroids or recent withdrawal from
systemic corticosteroids
C. difficulty perceiving airflow obstruction or its severity
D. rural residence - ANS ✓D
An 18-year-old high school senior presents, asking for a letter stating that
he should not participate in gym class because he has asthma. The most
appropriate action is to:
A. write the note because gym class participation could trigger asthma
symptoms.
B. excuse him from outdoor activities only to avoid pollen exposure.
C. assess his level of asthma control and make changes in his treatment
plan if needed so he can participate.
D. write a note excusing him from gym until his follow-up exam in 2
months. - ANS ✓C
You see a 34-year-old man with moderate persistent asthma who has a
severe asthma flare and a regimen of oral prednisone is being considered.
Which of the following is true?
A. A taper is needed for prednisone therapy lasting longer than 4 days.
B. A taper is not needed if the prednisone regimen is for 7 days or less.
C. A taper is not needed regardless of duration of prednisone therapy.
D. A taper is needed if the patient is taking concomitant inhaled
corticosteroids. - ANS ✓B
After inhaled corticosteroid is initiated, improvement in control is usually
seen:
Page 2 of 28
, 3
RESPIRATORY
A. on the first day of use.
B. within 2 to 8 days.
C. in about 3 to 4 weeks.
D. in about 1 to 2 months. - ANS ✓B
Compared with albuterol, levalbuterol (Xopenex) has:
A. a different mechanism of action.
B. the ability potentially to provide greater bronchodilation with a lower
dose.
C. an anti-inflammatory effect similar to that of an inhaled corticosteroid.
D. a contraindication to use in elderly patients. - ANS ✓B
Which of the following is consistent with the NAEPP comment on the use of
inhaled corticosteroids (ICS) for a child with asthma?
A. The potential but small risk of delayed growth with ICS is well balanced
by their effectiveness.
B. ICS should be used only if leukotriene modifiers fail to control asthma.
C. Permanent growth stunting is consistently noted in children using ICS.
D. Leukotriene modifiers are equal in therapeutic effect to the use of a long-
acting beta2-agonist. - ANS ✓A
A potential adverse effect from ICS use is:
A. oral candidiasis.
B. tachycardia.
C. gastrointestinal upset.
D. insomnia. - ANS ✓A
Page 3 of 28
